69448-019 : Imuldosa 130 mg/26ml Intravenous Injection
NDC: | 69448-019 |
Labeler: | Accord Biopharma Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | ![]() |
Dosage Form: | Intravenous Injection |
Application #: | BLA761364 |
Rev. Date: |
NDC Package Codes:
- 69448-019-26: 1 VIAL, SINGLE‑USE IN 1 CARTON (69448‑019‑26) / 26 ML IN 1 VIAL, SINGLE‑USE
Active Ingredients:
- Ustekinumab
Dosage Strength:
- 130 mg/26mL
Pharmaceutical Classes:
- Interleukin-12 Antagonist [EPC]
- Interleukin-12 Antagonists [MoA]
- Interleukin-23 Antagonist [EPC]
- Interleukin-23 Antagonists [MoA]
Related Products:
Based on records with the same trade name.- 69448-017 Imuldosa 45 mg/.5ml Subcutaneous Injection by Accord Biopharma Inc.
- 69448-018 Imuldosa 90 mg/ml Subcutaneous Injection by Accord Biopharma Inc.
- 51407-929 Imuldosa 45 mg/.5ml Subcutaneous Injection by Golden State Medical Supply, Inc.
- 51407-930 Imuldosa 90 mg/ml Subcutaneous Injection by Golden State Medical Supply, Inc.
- 51407-931 Imuldosa 130 mg/26ml Intravenous Injection by Golden State Medical Supply, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 69448-018Next: 69448-023 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.